Cimiracemoside C
Product Specifications
UNSPSC Description
Cimiracemoside C is an active component of Cimicifuga racemosa, activates AMPK, has the potential activity against diabetes[1].
Target Antigen
AMPK
Type
Natural Products
Related Pathways
Epigenetics;PI3K/Akt/mTOR
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/cimiracemoside-c.html
Purity
99.55
Solubility
DMSO : 5 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
C[C@]12[C@@]3([H])[C@@]4(CC[C@@]1([C@]5([H])C(O[C@H](C(C)(O)C)[C@@]6([H])C[C@H]5C)(O6)[C@@H]2O)C)[C@@]7([C@@](C(C)([C@@H](O[C@@]8([H])[C@@H]([C@H]([C@@H](O)CO8)O)O)CC7)C)([H])CC3)C4
Molecular Weight
620.81
References & Citations
[1]Moser C, et al. Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice. Phytomedicine. 2014 Sep 25;21(11):1382-9.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-N6971/Cimiracemoside-C-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N6971/Cimiracemoside-C-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
256925-92-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC201752L1V 200 µL
HADHSC (HADH) (NM_005327) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details